Public Comment on Draft Recommendation Statement and Draft Evidence Review: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer - US Preventive Services Task Force

Opportunity for Public Comment - US Preventive Services Task Force

Draft Recommendation Statement and Draft Evidence Review: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer

Public Comment on Draft Recommendation Statement and Draft Evidence Review: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer. The Task Force found that testing is beneficial for the small number of women in the United States who are at increased risk for BRCA1 or BRCA2 mutations. The draft recommendation statement and draft evidence review are available for review and public comment from February 19, 2019 to March 18, 2019 here. The Draft Recommendation Statement and Draft Evidence Review Are Open to Public Comment

COMMENTING DETAILS

Public Comment Period: 2/19/19 - 3/18/19 Any visitor to the Task Force Web site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population Recommendation Grade Women whose family history or ethnicity/ancestry is associated with an increased risk for harmful BRCA mutations The USPSTF recommends that primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal cancer or have an ethnicity or ancestry associated with BRCA1 or BRCA2 gene mutations with one of several screening tools designed to identify a family history that may be associated with an increased risk for potentially harmful mutations in breast cancer susceptibility genes (BRCA1 or BRCA2). Women with positive screening results should receive genetic counseling and, if indicated after counseling, genetic testing. B Women whose family history or ethnicity/ancestry is not associated with an increased risk for harmful BRCA mutations The USPSTF recommends against routine screening, genetic counseling, or genetic testing for women whose family or personal history or ethnicity or ancestry is not associated with an increased risk for potentially harmful mutations in the BRCA1 or BRCA2 genes. D

See the full draft recommendation statement

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation / Draft Evidence Review Final Recommendation / Evidence Summary